Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles

• Prif Awduron: Antonietta Vilella (Awdur), Barbara Ruozi (Awdur), Daniela Belletti (Awdur), Francesca Pederzoli (Awdur), Marianna Galliani (Awdur), Valentina Semeghini (Awdur), Flavio Forni (Awdur), Michele Zoli (Awdur), Maria Angela Vandelli (Awdur), Giovanni Tosi (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: MDPI AG, 2015-06-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

The success of nanomedicine as a new strategy for drug delivery and targeting prompted the interest in developing approaches toward basic and clinical neuroscience. Despite enormous advances on brain research, central nervous system (CNS) disorders remain the world's leading cause of disability...